Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 406
Filter
1.
J Frailty Aging ; 12(3): 182-188, 2023.
Article in English | MEDLINE | ID: mdl-37493378

ABSTRACT

BACKGROUND: Muscle response in older adults is believed to decrease with maximal muscle strength, although it has not been adequately assessed; further, the relationship between frailty and muscle response remains unexamined. OBJECTIVES: This study aimed to develop a practical method for measuring muscle response using grip strength in older adults and to clarify the relationship between frailty and grip strength response. DESIGN, SETTING, AND PARTICIPANTS: We performed a cross-sectional, clinical, observational study. A total of 248 patients (94 men and 154 women, mean age: 78.2 years) who visited the outpatient unit in the Integrated Healthy Aging Clinic of our Hospital for the first time were enrolled. MEASUREMENTS: Using a grip strength measuring device originally developed by us, we measured grip strength response indices, such as reaction time, time constant, rate of force development (response speed), and maximum grip strength. Grip strength response indices were compared among three groups (robust, pre-frail, and frail) according to the Fried and Kihon checklist assessments for frailty. RESULTS: Based on Fried's assessment, marked differences were found between groups not only in maximal grip strength but also in response time and response speed. Based on the Kihon checklist assessment, there was no significant difference in response time; however, a considerable difference in response speed for the left hand was observed. Moreover, according to the Kihon checklist assessment, some cases showed differences in muscle response although not in maximal muscle strength. CONCLUSIONS: The response speed of grip strength was suggested to decrease with frailty. The results suggest that measurement of grip strength response in both hands is useful to examine the relationship between frailty and grip strength response.


Subject(s)
Frailty , Male , Aged , Humans , Female , Frailty/diagnosis , Reaction Time , Frail Elderly , Cross-Sectional Studies , Geriatric Assessment/methods , Hand Strength
3.
J Hosp Infect ; 134: 97-107, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36805085

ABSTRACT

BACKGROUND: The risk factors for coronavirus disease (COVID-19) among healthcare workers (HCWs) might have changed since the emergence of the highly immune evasive Omicron variant. AIM: To compare the risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCWs during the Delta- and Omicron-predominant periods. METHODS: Using data from repeated serosurveys among the staff of a medical research centre in Tokyo, two cohorts were established: Delta period cohort (N = 858) and Omicron period cohort (N = 652). The potential risk factors were assessed using a questionnaire. Acute/current or past SARS-CoV-2 infection was identified by polymerase chain reaction or anti-nucleocapsid antibody tests, respectively. Poisson regression was used to calculate the risk ratio (RR) of infection risk. FINDINGS: The risk of SARS-CoV-2 infection during the early Omicron-predominant period was 3.4-fold higher than during the Delta-predominant period. Neither working in a COVID-19-related department nor having a higher degree of occupational exposure to SARS-CoV-2 was associated with an increased infection risk during both periods. During the Omicron-predominant period, infection risk was higher among those who spent ≥30 min in closed spaces, crowded spaces, and close-contact settings without wearing mask (≥3 times versus never: RR: 6.62; 95% confidence interval: 3.01-14.58), whereas no such association was found during the Delta period. CONCLUSION: Occupational exposure to COVID-19-related work was not associated with the risk of SARS-CoV-2 infection in the Delta or Omicron period, whereas high-risk behaviours were associated with an increased infection risk during the Omicron period.


Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , Japan/epidemiology , SARS-CoV-2 , Risk Factors , Health Personnel
4.
Int J Obstet Anesth ; 41: 59-64, 2020 02.
Article in English | MEDLINE | ID: mdl-31358431

ABSTRACT

BACKGROUND: Intra-operative cell salvage is not routinely used during cesarean delivery because it is not cost-effective for patients at low risk of hemorrhage and there are theoretical concerns about amniotic fluid embolism. Some guidelines recommend using leukocyte depletion filters to decrease the risk of amniotic fluid embolism before re-infusing salvaged blood, but these filters are not available in Japan. We compared the efficacy and safety of leukocyte depletion and micro-aggregate filters in combination with intra-operative cell salvage during cesarean delivery. METHODS: Blood was collected in a Cell Saver 5 reservoir during cesarean delivery. Four samples were collected: pre-wash, post-wash, post-filtration with a leukocyte depletion filter and post-filtration with a micro-aggregate filter. Each sample was analyzed for amniotic fluid markers of zinc coproporphyrin-1 and sialyl-Tn, for fetal hemoglobin, and the sample underwent pathological examination for white blood cells and squamous cells. Post-filtration samples were compared using paired t-tests with P <0.05 indicating statistical significance. RESULTS: Zinc coproporphyrin-1 and sialyl-Tn were negative at almost all sample points. Squamous cells decreased by 59.1% post-wash and 91.2% post-filtration using a leukocyte depletion filter. Leukocyte depletion filters removed 99.7% of white blood cells and were more effective in removing white blood cells than micro-aggregate filters (P=0.02). CONCLUSION: Leucocyte depletion filters are more effective in removing white blood cells and squamous cells than micro-aggregate filters, and their introduction for intra-operative cell salvage during cesarean delivery should be considered in Japanese clinical practice.


Subject(s)
Cesarean Section , Embolism, Amniotic Fluid/prevention & control , Leukocyte Reduction Procedures/instrumentation , Operative Blood Salvage/methods , Adult , Female , Filtration/instrumentation , Humans , Pregnancy
5.
Pharmazie ; 73(7): 393-395, 2018 07 01.
Article in English | MEDLINE | ID: mdl-30001773

ABSTRACT

Lycopene, the main fat-soluble pigment responsible for the red color of ripe tomatoes, is a symmetrical tetraterpene comprising eight isoprene units. In vitro and in vivo studies have shown that lycopene acts as a potent antioxidant; it is 100 times more effective than vitamin E and 125 times more effective than glutathione as an antioxidant. Here, we divided BALB/c male mice into three equal groups: control, Concanavalin A (Con A), and Con A and lycopene. The control group mice received only vehicle by intraperitoneal injection, the Con A group mice were given Con A, and the Con A and lycopene group mice received Con A and lycopene. The results showed that Con A administration increased histopathological damage, and the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), interleukin (IL)-6, interferon (IFN)-γ and tumor necrosis factor (TNF)-α were increased in serum samples whereas the levels of these compounds were significantly decreased in the Con A and lycopene group compared to the Con A group. Furthermore, we observed that lycopene led to an increase in cell viability and cell growth. The results of this study revealed that lycopene might be a useful hepatoprotective agent for reducing increased proinflammatory cytokine levels, and for increasing cell viability and cell growth.


Subject(s)
Antioxidants/pharmacology , Cell Survival/drug effects , Liver Diseases/prevention & control , Lycopene/pharmacology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Concanavalin A/toxicity , Disease Models, Animal , Interferon-gamma/blood , Interleukin-6/blood , Male , Mice , Mice, Inbred BALB C , Tumor Necrosis Factor-alpha/blood
6.
AIDS Care ; 30(11): 1356-1359, 2018 11.
Article in English | MEDLINE | ID: mdl-29920118

ABSTRACT

Transwomen of color are disproportionately impacted by HIV and may have worse health outcomes than other populations. This analysis was conducted to examine structural factors associated with poor health outcomes among transwomen of color living with HIV in the San Francisco Bay Area (N = 159). Univariate and multivariable analyses were conducted to determine if structural factors were associated with poor HIV-related health outcomes. A majority of participants were Black or African American (110/159, 69.2%), 32 (20.1%) identified their primary race/ethnicity as Hispanic or Latino/a or Spanish, and 17 (10.7%) identified as another race/ethnicity. Transwomen of color in our sample faced extreme structural barriers, including residential transience, extreme low income, high prevalence of running out of money in the last six months, high rates of food insecurity, high prevalence of income via entitlement programs, engagement in sex work and other illicit activities for income. Unstable housing was the structural factor most consistently associated with poor health outcomes along the HIV care continuum and may explain engagement in other sources of income generation. Interventions are needed that go beyond the individual and health care-level to address needs for housing and economic opportunities to improve HIV care outcomes among transwomen of color living with HIV in the San Francisco Bay Area.


Subject(s)
Black or African American , Continuity of Patient Care , HIV Infections/epidemiology , Hispanic or Latino , Housing , Income , Transgender Persons , Adult , Female , HIV Infections/drug therapy , Humans , Poverty , Prevalence , San Francisco/epidemiology , Sex Work
7.
J Neuroendocrinol ; 28(12)2016 12.
Article in English | MEDLINE | ID: mdl-27801962

ABSTRACT

Corticotrophin-releasing factor (CRF) regulates the hypothalamic-pituitary-adrenal axis response to stress through its type 1 receptor (CRF1 ) in the corticotrophs of the anterior pituitary. Although CRF1 mRNA expression has been confirmed in the rat pituitary, the distribution pattern of CRF1 protein in the pituitary has not been reported. Therefore, we generated an antiserum against the amino acid fragment corresponding to the 177-188 sequence of the first extracellular loop of the rat CRF1 . Using the antiserum, CRF1 -like immunoreactivity (CRF1 -LI) was detected in the anterior lobe cells of the rat pituitary where some of them expressed intense signals. CRF1 -LI also appeared in the intermediate lobe cells and on the fibre-like elements of the posterior lobe of the pituitary. Dual immunofluorescence labelling showed that corticotrophs exhibited the highest percentage of CRF1 (male: 27.1 ± 3.0%, female: 18.0 ± 3.0%), followed by lactotrophs (male: 6.7 ± 3.0%, female: 12.1 ± 1.3%), gonadotrophs (male: 2.6 ± 1.0%, female: 7.5 ± 0.5%), thyrotrophs (male: 2.9 ± 0.1%, female: 5.3 ± 1.2%) and somatotrophs (male: 1.1 ± 0.3%, female: 1.2 ± 0.5%). The percentage of CRF1 -LI-positive cells that were corticotrophs was significantly higher in male rats than in female rats, whereas CRF1 -LI-positive lactotrophs and gonadotrophs were significantly higher in female rats than in male rats. Almost all of the melanotrophs were positive for CRF1 in the intermediate lobe (98.9 ± 0.2%). CRF1 -LI and the percentage of CRF1 -LI in corticotrophs were decreased in the anterior pituitary, and the distribution patterns were altered from a diffuse to punctate one by adrenalectomy; the changes were restored by treatment with dexamethasone (100 µg/kg bw). These results suggest that CRF1 is involved in the modulation of the functions of the pituitary; moreover, protein expression and the distribution patterns of CRF1 are regulated by glucocorticoids in the rat anterior pituitary.


Subject(s)
Pituitary Gland, Anterior/metabolism , Pituitary Gland/metabolism , Receptors, Corticotropin-Releasing Hormone/metabolism , Adrenalectomy , Animals , Corticotrophs/drug effects , Corticotrophs/metabolism , Dexamethasone/administration & dosage , Female , Glucocorticoids/administration & dosage , Gonadotrophs/drug effects , Gonadotrophs/metabolism , Immunohistochemistry , Lactotrophs/drug effects , Lactotrophs/metabolism , Male , Pituitary Gland/drug effects , Pituitary Gland, Anterior/drug effects , Primary Cell Culture , Rats, Wistar , Receptors, Corticotropin-Releasing Hormone/immunology , Somatotrophs/drug effects , Somatotrophs/metabolism , Thyrotrophs/drug effects , Thyrotrophs/metabolism
8.
Eur Psychiatry ; 30(8): 995-1001, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26497470

ABSTRACT

BACKGROUND: The mode of onset and the course of schizophrenia illness exhibit substantial individual variations. Previous studies have pointed out that the mode of onset affects the duration of untreated psychosis (DUP) and clinical outcomes, such as cognitive and social functioning. This study attempted to clarify the association between the DUP and clinical features, taking the different modes of onset into consideration, in a prospective longitudinal study examining patients with first-episode schizophrenia. METHODS: This study was conducted in six areas of Japan. Patients with first-episode schizophrenia were followed for over 18 months. Cognitive function, psychopathology, and social functioning were assessed at baseline and at 6, 12, and 18-month follow-up points. RESULTS: We identified 168 patients and sufficient information was available to determine the DUP and the mode of onset for 156 patients (92.9%): 79 had an acute onset, and 77 had an insidious onset. The DUP was significantly associated with quality of life (QOL), social functioning, and cognitive function at most of the follow-up points in the insidious-onset group. The DUP and negative symptoms at baseline were significant predictors of cognitive function at the 18-month follow-up in the insidious-onset group. CONCLUSIONS: The present results further support the hypothesis that the DUP affects QOL, social functioning, and cognitive function over the course of illness, especially in patients with an insidious onset. Effective strategies for detecting and caring for individuals with insidious onset early during the course of schizophrenia will be essential for achieving a full patient recovery.


Subject(s)
Antipsychotic Agents/therapeutic use , Cognition , Quality of Life , Schizophrenia , Adolescent , Adult , Age of Onset , Female , Humans , Japan/epidemiology , Longitudinal Studies , Male , Outcome Assessment, Health Care , Prospective Studies , Psychological Techniques , Psychotic Disorders/therapy , Schizophrenia/diagnosis , Schizophrenia/epidemiology , Schizophrenia/therapy , Schizophrenic Psychology , Social Skills , Time-to-Treatment
9.
Br J Pharmacol ; 171(23): 5376-86, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25048778

ABSTRACT

BACKGROUND AND PURPOSE: Activation of δ opioid (DOP) receptors regulates pain and emotional responses, and also displays ligand-biased agonism. KNT-127 (1,2,3,4,4a,5,12,12a-octahydro-2-methyl-4aß,1ß-([1,2]benzenomethano)-2,6-diazanaphthacene-12aß,17-diol) is a novel DOP receptor agonist inducing analgesia and antidepressant effects in mice. Here, we have assessed KNT-127 for (i) analgesia against chronic inflammatory pain; (ii) effects on depression, locomotion and DOP receptor internalization; and (iii) for cross-tolerance to analgesic and antidepressant effects of acute treatment by other DOP receptor agonists. EXPERIMENTAL APPROACH: Inflammatory pain was induced by complete Freund's adjuvant injection into tail or hindpaw, and thermal and mechanical sensitivities were determined in mice. Locomotor and antidepressant-like effects were measured using actimetry and forced swim test respectively. In vivo KNT-127 selectivity and internalization were assessed using DOP receptor knockout mice and knock-in mice expressing fluorescent-tagged DOP receptors. KNT-127 was injected acutely at 0.1-10.0 mg·kg(-1) or administered chronically at 5 mg·kg(-1) daily over 5 days. KEY RESULTS: Acute treatment with KNT-127 reversed inflammatory hyperalgesia, produced an antidepressant-like effect but induced neither hyperlocomotion nor receptor sequestration. Chronic treatment with KNT-127 induced tolerance and cross-tolerance to SNC80-induced analgesia, but no tolerance to SNC80-evoked hyperlocomotor or antidepressant-like effects. CONCLUSIONS AND IMPLICATIONS: The DOP receptor agonist KNT-127 induced agonist-specific acute and chronic responses, at both behavioural and cellular levels. It displays activities similar to the other recently reported DOP agonists, AR-M1000390, ADL5747 and ADL5859, and differs from SNC80. SNC80 differs from the other DOP receptor agonists including KNT-127, by exhibiting ligand-biased tolerance at this receptor.


Subject(s)
Analgesics/therapeutic use , Antidepressive Agents/therapeutic use , Depression/drug therapy , Morphinans/therapeutic use , Pain/drug therapy , Receptors, Opioid, delta/agonists , Analgesics/pharmacology , Animals , Antidepressive Agents/pharmacology , Behavior, Animal/drug effects , Benzamides/pharmacology , Drug Tolerance , Freund's Adjuvant , Hot Temperature , Hyperalgesia/drug therapy , Male , Mice, Inbred C57BL , Mice, Knockout , Morphinans/pharmacology , Motor Activity/drug effects , Pain/etiology , Piperazines/pharmacology , Receptors, Opioid, delta/genetics , Receptors, Opioid, delta/metabolism
10.
J Frailty Aging ; 3(3): 142-7, 2014.
Article in English | MEDLINE | ID: mdl-27050059

ABSTRACT

BACKGROUND: We developed a new grip strength measuring device, which considers the time axis, for evaluating muscle contraction in detail in elderly people. OBJECTIVES: To present the novel device and preliminary results concerning agility in gripping. DESIGN: Cross-sectional analysis. PARTICIPANTS: One hundred and twenty-one older persons (48 men and 73 women, mean age 74.4 years) referring for memory disorders to the outpatient clinic of our institute. MEASUREMENTS: A novel device taking advantage of an industrial force-gauge was developed for measuring gripping performance. The instrument graphically described participants' strength production. Nine indices were derived from four points identified by the graph: 1) starting point ("Go signal"), 2) time when gripping starts, 3) turning point (TP) when the inclination of the curve depicting strength production changes, and 4) peak of strength production. Results obtained from the study sample of older persons were compared (as ratios) to a control group of 30 healthy young adults in their thirties in order to calculate age-related decline rates. Differences between right and left side were compared. RESULTS: A significant difference was observed between right and left hands concerning the time to reach peak of strength, and time from TP to strength peak in both men and women. For women, the following indices were also significantly different: time to reach TP, strength at TP, time from TP to strength peak, curve inclination from TP to strength peak, and ratio of TP strength divided by peak strength. CONCLUSION: Declines in several indices of gripping agility were measured. The parameters which were more closely related to time than strength itself showed significant differences between right and left hands, especially in women.

11.
Cell Biochem Funct ; 31(8): 652-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23339033

ABSTRACT

Simvastatin suppresses myoblast differentiation via inhibition of Rac GTPase, which is involved in the mevalonic acid pathway that produces cholesterol. Statins also inhibit adipogenic differentiation and receptor activator of NFκB ligand (RANKL) expression, possibly through the mevalonic acid pathway, although the involvement of that pathway and effector proteins in these cellular events has not been fully clarified. In the present study, we aimed to elucidate the mechanism of the effects of simvastatin on adipogenic differentiation and calcitriol-induced RANKL expression in bone marrow stromal ST2 cells. Adipogenesis and mRNA up-regulation of peroxisome proliferator-activated receptor γ and adipocyte fatty acid-binding protein were induced by troglitazone, and those events were efficiently inhibited by simvastatin. In addition, RANKL expression induced by calcitriol was abrogated by simvastatin in ST2 cells. The inhibitory effects of simvastatin were adequately compensated by the addition of either mevalonic acid or an intermediate of the mevalonic acid pathway, geranylgeranyl pyrophosphate, but not by another intermediate, farnesyl pyrophosphate. These findings suggest that protein geranylgeranylation is related to cellular differentiation in those two directions. Furthermore, inhibitor analysis demonstrated that Rac GTPase is involved in adipogenic differentiation, whereas Rho GTPase was found to be involved in RANKL expression. Taken together, the present findings suggest that geranylgeranylation of Rho family GTPase is involved in both adipogenesis and RANKL expression of stromal cells, while Rac GTPase is involved in adipogenesis and Rho GTPase in RANKL expression.


Subject(s)
Adipocytes/drug effects , Adipogenesis , Prenylation , RANK Ligand/biosynthesis , Simvastatin/pharmacology , rac GTP-Binding Proteins/metabolism , rho GTP-Binding Proteins/metabolism , Adipocytes/cytology , Adipocytes/metabolism , Adipogenesis/drug effects , Animals , Cell Differentiation/drug effects , Cells, Cultured , Enzyme Activation , Mevalonic Acid/metabolism , Mice , Prenylation/drug effects , RANK Ligand/antagonists & inhibitors
12.
East Asian Arch Psychiatry ; 22(3): 110-3, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23019284

ABSTRACT

Early intervention for psychosis in Japan has lagged behind that in western countries, but has rapidly begun to attract attention in recent years. As part of a worldwide trend, a multi-dimensional treatment centre for early psychosis consisting of a Youth Clinic, which specialises in young individuals with an at-risk mental state for psychosis, and Il Bosco, a special day-care service for individuals with early psychosis, was initiated at the Toho University Omori Medical Center in Japan in 2007. The treatment centre aims to provide early intervention to prevent the development of full-blown psychosis in patients with an at-risk mental state and intensive rehabilitation to enable first-episode schizophrenia patients to return to the community. We presently provide the same programmes for both groups at Il Bosco. However, different approaches may need to be considered for patients with an at-risk mental state and for those with first-episode schizophrenia. More phase-specific and need-specific services will be indispensable for early psychiatric interventions in the future.


Subject(s)
Early Medical Intervention/methods , Mental Health Services/organization & administration , Program Development , Psychotic Disorders/therapy , Community Participation/methods , Humans , Japan
13.
Indian J Biochem Biophys ; 49(6): 421-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23350276

ABSTRACT

Proenzymes with various lengths of propeptides have been observed in GluV8 from Staphylococcus aureus and GluSE from S. epidermidis. However, the production mechanism of these proenzymes and roles of truncated propeptides have yet to be elucidated. Here we demonstrate that shortening of propeptide commonly occurs in an auto-catalytic manner in GluV8-family members, including those from coagulase negative Staphylococci and Enterococcus faecalis. Accompanied with propeptide shortening, the pro-mature junction (Asn/Ser_1-Val1) becomes more susceptible towards the hetero-catalytic maturation enzymes. The auto-catalytic propeptide truncation is not observed in Ser169Ala inert molecules of GluV8-family members. A faint proteolytic activity of proenzymes from Staphylococcus caprae and E. faecalis is detected. In addition, proteolytic activity of proenzyme of GluV8 carrying Arg-3AlaAsn.1 is demonstrated with synthetic peptide substrates LLE/Q-MCA. These results suggest that GluV8-family proenzymes with shortened propeptides intrinsically possess proteolytic activity and are involved in the propeptide shortening that facilitates the final hetero-catalytic maturation.


Subject(s)
Enterococcus/enzymology , Enzyme Precursors/metabolism , Peptide Fragments/metabolism , Protein Processing, Post-Translational , Serine Endopeptidases/metabolism , Staphylococcus aureus/enzymology , Staphylococcus epidermidis/enzymology , Amino Acid Sequence , Enterococcus/drug effects , Enterococcus/genetics , Immunoblotting , Molecular Sequence Data , Mutagenesis , Mutation/genetics , Proteolysis , Sequence Homology, Amino Acid , Serine Endopeptidases/genetics , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/genetics , Thermolysin/pharmacology
15.
J Dent Res ; 90(6): 793-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21393550

ABSTRACT

Excessive mechanical stress (MS) during hyperocclusion is known to result in disappearance of the alveolar hard line, enlargement of the periodontal ligament (PDL) space, and destruction of alveolar bone, leading to occlusal traumatism. We hypothesized that MS induces expression of osteoclastogenesis-associated chemokines in PDL tissue, resulting in chemotaxis and osteoclastogenesis during occlusal traumatism. We examined the effect of MS on relationships between chemokine expression and osteoclastogenesis using in vivo and in vitro hyperocclusion models. In an in vitro model, intermittent stretching-induced MS was shown to up-regulate the expression of CC chemokine ligand (CCL)2, CCL3, and CCL5 in PDL cells. The expression levels of CCL2 in PDL tissues, its receptor CCR2 in pre-osteoclasts, and tartrate-resistant acid-phosphatase-positive cells in alveolar bone were significantly up-regulated 4-7 days after excessive MS during hyperocclusion in in vivo rodent models. Hyperocclusion predominantly induced CCL2 expression in PDL tissues and promoted chemotaxis and osteoclastogenesis, leading to MS-dependent alveolar bone destruction during occlusal traumatism.


Subject(s)
Alveolar Bone Loss/metabolism , Chemokine CCL2/biosynthesis , Dental Occlusion, Traumatic/metabolism , Osteoclasts , Periodontal Ligament/metabolism , Analysis of Variance , Animals , Bite Force , Cell Differentiation , Cells, Cultured , Chemotaxis, Leukocyte , Dental Stress Analysis , Humans , Mice , Mice, Inbred Strains , Oligonucleotide Array Sequence Analysis , Osteoclasts/cytology , Osteoclasts/metabolism , Periodontal Ligament/cytology , Periodontal Ligament/physiopathology , RANK Ligand/metabolism , Rats , Rats, Wistar , Receptors, CCR2/biosynthesis , Stress, Mechanical
16.
J Oral Rehabil ; 38(9): 661-7, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21323724

ABSTRACT

Jerk-cost is an inverse measure of movement smoothness and can be calculated from the first-time derivative of acceleration obtained from a tri-axial piezoelectric accelerometer (TPA), or from the third-time derivative of position obtained from a jaw-tracking device. The aims of this study were to determine, in 10 asymptomatic subjects who are chewing gum, (i) jerk-cost measures derived from displacement/time data obtained from the JAWS3D jaw-tracking device and from acceleration data obtained from a TPA used in the same jaw movement recordings, (ii) whether there was a significant relationship between jerk-cost measures derived from both devices and (iii) the degree of agreement between the two measures. Jerk-cost data were calculated in the opening phase, the closing phase, and over the full chewing cycle as the first-time derivative from acceleration obtained from the TPA, and the third-time derivative from JAWS3D for each of the X-, Y- and Z-direction series. There was a significant correlation between both measures of jerk-cost over the full chewing cycle and during jaw-opening (r = 0·65, 0·75, respectively; P < 0·001). There was no significant correlation in the closing phase (r = -0·02, P = 0·99). The Bland-Altman test showed that jerk-cost derived from the JAWS3D can differ by up to 78% below and 21% above that derived from the TPA. These results suggest that jerk-cost measures derived from a jaw-tracking system cannot substitute for jerk-cost measures derived from an accelerometer.


Subject(s)
Actigraphy/methods , Jaw/physiology , Mastication/physiology , Movement/physiology , Acceleration , Actigraphy/instrumentation , Adult , Algorithms , Biomechanical Phenomena , Chewing Gum , Female , Humans , Male , Reproducibility of Results , Software , Young Adult
17.
Dis Esophagus ; 23(8): 641-5, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20545978

ABSTRACT

The chemotherapy regimen currently used for treating esophageal and gastric carcinoma has been either epirubicin, cisplatin, and fluorouracil (5-FU) or docetaxel, cisplatin, and 5-FU. Here, we report the efficacy and toxicity of doxorubicin, cisplatin, and 5-FU for only esophageal squamous cell carcinoma (ESCC). Between January 2000 and October 2008, a total of 41 ESCC patients with a distant metastasis were enrolled. The most common sites of metastasis were liver (26, 63.4%), lung (9, 22.0%), and bone (8, 19.5%). Doxorubicin was administered on day 1 at 30 mg/m(2) , cisplatin on days 1-5 at 14 mg/m(2)/day, and 5-FU on days 1-5 at 700 mg/m(2)/day. The median number of cycles was 2.0 (range 1-8). The dose intensities of doxorubicin, cisplatin, and 5-FU were 92.9, 92.4, and 92.5%, respectively. The overall response rate was 43.9%; one showed complete response, 17 showed partial response, 13 showed a stable disease, and 10 showed progressive disease (PD). The median survival time was 306 days (95% CI = 74-935) and the 1-year survival rate was 37.6%. Grade 3 neutropenia was seen in seven patients and grade 4 in one patient. Grade 3 fatigue, anorexia, mucositis, and diarrhea were observed in three, two, two, and one patient, respectively. This regimen is effective as a first-line therapy for ESCC with distant metastasis.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols , Bone Neoplasms/secondary , Carcinoma, Squamous Cell/secondary , Esophageal Neoplasms , Liver Neoplasms/secondary , Lung Neoplasms/secondary , Aged , Bone Neoplasms/drug therapy , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/mortality , Cisplatin/administration & dosage , Cisplatin/adverse effects , Disease Progression , Docetaxel , Drug Administration Schedule , Drug Interactions , Esophageal Neoplasms/drug therapy , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Female , Fluorouracil/administration & dosage , Fluorouracil/adverse effects , Humans , Liver Neoplasms/drug therapy , Lung Neoplasms/drug therapy , Male , Middle Aged , Neutropenia/chemically induced , Survival Rate , Taxoids/administration & dosage , Taxoids/adverse effects , Treatment Outcome
18.
J Oral Rehabil ; 37(8): 590-5, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20374437

ABSTRACT

Jerk-cost as a measure of jaw movement smoothness has been used to evaluate the masticatory function of patients with tooth loss and malocclusion. Jerk-cost measuring systems have thus far been unable to determine the jerk-cost of each chewing phase over time. The purposes of this study were (i) to develop a new method for measuring momentary jerk-cost of the jaw movement using a small triaxial piezoelectric accelerometer and (ii) to test the hypothesis that the lowest smoothness is seen during jaw-opening phase. The accelerometer was attached to the skin of the mentum of each subject. Vertical jaw displacement, acceleration, the jerk, and the time differential of jerk-cost during gum chewing were analysed as a function of time in five normal dentate subjects (n = 5). The system revealed intra-class correlation coefficients of intra-examiner, inter-examiner, and test-retest consistency of substantially high values (0.80-0.88). In all subjects, the highest jerk-cost was observed in the opening phase of each chewing cycle when the gum was parting from the teeth; the lowest jerk-cost was observed in the intercuspal phase throughout the chewing cycle, thus confirming the hypothesis. Significant differences were observed between the opening, closing, and intercuspal chewing phases (N = 5, P = 0.007). The smoothness measurement system used in this study evaluated the momentary smoothness of each chewing phase in the masticatory cycle. The system may serve as a diagnostic tool to evaluate the smoothness of the jaw movement in general dental practice.


Subject(s)
Mandible/physiology , Mastication/physiology , Acceleration , Adult , Algorithms , Biomechanical Phenomena , Chewing Gum , Female , Humans , Imaging, Three-Dimensional , Male , Movement , Software , Ultrasonics
19.
Int J Oral Maxillofac Surg ; 39(1): 61-7, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19913389

ABSTRACT

alpha-actinin-4, originally identified as an actin-binding protein associated with cell motility, invasion, and metastasis of cancer cells, appears to be overexpressed in various human epithelial carcinomas, including colorectal, breast, esophageal, ovarian, and non-small cell lung carcinomas. The authors evaluated whether alpha-actinin-4 might be appropriate as a molecular target for cancer gene therapy. In 64 primary oral squamous cell carcinomas (OSCCs) and 10 normal oral mucosal specimens, and in seven human OSCC cell lines, alpha-actinin-4 expression was evaluated immunologically and correlations with clinicopathologic factors were examined. Overexpression of alpha-actinin-4 was detected in 38 of 64 oral squamous cell carcinomas (70%); significantly more frequently than in normal oral mucosa. The expression of alpha-actinin-4 was significantly associated with invasion potential defined by the Matrigel invasion assay. Cancer cell lines with higher alpha-actinin-4 expression had greater invasive potential. An RNAi-mediated decrease in alpha-actinin-4 expression reduced the invasion potential. These results indicated that the overexpression of alpha-actinin-4 was associated with an aggressive phenotype of OSCC. The study indicated that alpha-actinin-4 could be a potential molecular target for gene therapy by RNAi targeting for OSCC.


Subject(s)
Actinin/genetics , Carcinoma, Squamous Cell/genetics , Down-Regulation/physiology , Gene Expression Regulation, Neoplastic/genetics , Mouth Neoplasms/genetics , RNA Interference/physiology , Actinin/analysis , Blotting, Western , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Cell Nucleus/ultrastructure , Cytoplasm/ultrastructure , Diffusion Chambers, Culture , Female , Gene Knockdown Techniques , Humans , Immunohistochemistry , Keratinocytes/cytology , Male , Middle Aged , Mouth Mucosa/cytology , Mouth Neoplasms/pathology , Neoplasm Invasiveness/genetics , Neoplasm Staging , Phenotype , RNA, Small Interfering/therapeutic use , Reverse Transcriptase Polymerase Chain Reaction
20.
Dis Esophagus ; 22(6): 505-12, 2009.
Article in English | MEDLINE | ID: mdl-19302209

ABSTRACT

We examined whether endocytoscopic observation of esophageal squamous cell carcinoma can replace the histologic examination of biopsy specimens. In a basic investigation, we examined 57 iodine-unstained areas in the resected specimens of the esophagus from 28 individuals. The endocytoscopic findings were graded from 0 to 3 in tandem with observations of the iodine staining. For endocytoscopic observation, we sprayed 1% methylene blue or toluidine blue as a vital dye on the surface of the esophageal mucosa, allowing 15-20 s for sufficient staining. One endoscopist observed the target lesions and decided their endocytoscopic type classification. Histological diagnoses were made by two pathologists who were unaware of the endoscopic findings. We then compared the endocytoscopic diagnosis and conventional histological diagnosis. In an in vivo investigation, we examined 71 lesions of esophageal squamous cell carcinoma. Two endoscopists diagnosed the type classification in consultation with a pathologist with regard to 'nuclear density,''nuclear abnormality,' and 'whether biopsy histology could have been omitted on the basis of endocytoscopic findings.' For the in vivo observation, we utilized XEC120U (higher magnification type [x1100]), XEC300F (lower magnification type [x450]), and XGIF-Q260EC1 (lower magnification type [x450]) instruments. In the basic investigation, among the 11 areas classified as Type 1, 10 (91%) were category 1 by the Vienna classification. Among the 39 lesions classified as Type 3, 36 (92%) were category 4 or 5. The sensitivity of endocytoscopy for malignant lesions (Vienna classification categories 4 and 5) was 94.7%, if Type 3 was considered malignant. The specificity was 84.2% according to the same criteria. In the in vivo observation, two endoscopists diagnosed more than 90% of esophageal squamous cell carcinomas as neoplasms using each type of endocytoscope. With regard to nuclear density, the pathologist considered it to be increased in 98% of cases with the XEC120U, in 94% with the XEC300F, and in 93% with the XGIF-Q260EC1. With regard to nuclear abnormality, the positivity rate was 90% with the XEC120U, 78% with the XEC300F, and 80% with the XGIF-Q260EC1. As to whether or not biopsy histology examination was considered necessary, the pathologist made a 'Yes' judgment for 84% of cases observed with the XEC120U, 66% with the XEC300F, and 67% with the XGIF-Q260EC1. Cancerous lesions diagnosed as Type 3 by both endoscopists using the XEC120U accounted for 46 (90.2%) of the 51 cases. Among these 46 cases, biopsy histology was considered unnecessary by the pathologist in 43 (93.5%). We believe that endocytoscopic observation has the potential to reduce the extent of histologic examination of biopsy specimens in cases corresponding to Types 1 and 3 of our classification.


Subject(s)
Carcinoma, Squamous Cell/pathology , Esophageal Neoplasms/pathology , Esophagoscopy/methods , Cell Nucleus/pathology , Endoscopes, Gastrointestinal , Equipment Design , Humans , Image Processing, Computer-Assisted , Microscopy, Confocal , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...